CompletedNot applicableNCT03284268

Evaluate Safety and the Oncolitic Adenovirus VCN-01 Activity in Patients With Refractory Retinoblastoma

Studying Hereditary retinoblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fundació Sant Joan de Déu
Principal Investigator
Jaume Catalá Mora, Dr
Hospital Sant Joan de Deu
Intervention
VCN-01(genetic)
Enrollment
13 enrolled
Eligibility
1-12 years · All sexes
Timeline
2017 – 2024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03284268 on ClinicalTrials.gov

Other trials for Hereditary retinoblastoma

Additional recruiting or active studies for the same condition.

See all trials for Hereditary retinoblastoma →

← Back to all trials